1 – 10 of 16
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Elevated expression of complement factor I in lung cancer cells associates with shorter survival–Potentially via non-canonical mechanism
(
- Contribution to journal › Article
- 2023
-
Mark
KRAS G12C Mutant Non–Small Cell Lung Cancer Linked to Female Sex and High Risk of CNS Metastasis : Population-based Demographics and Survival Data From the National Swedish Lung Cancer Registry
(
- Contribution to journal › Article
-
Mark
A trans-omics assessment of gene–gene interaction in early-stage NSCLC
(
- Contribution to journal › Article
-
Mark
Non-small cell lung cancer patients treated with Anti-PD1 immunotherapy show distinct microbial signatures and metabolic pathways according to progression-free survival and PD-L1 status
(
- Contribution to journal › Article
- 2021
-
Mark
Infiltration of NK and plasma cells is associated with a distinct immune subset in non-small cell lung cancer
(
- Contribution to journal › Article
-
Mark
PD-L1 Testing in Cytological Non-Small Cell Lung Cancer Specimens : A Comparison with Biopsies and Review of the Literature
(
- Contribution to journal › Article
- 2020
-
Mark
Dna polymerase alpha subunit b is a binding protein for erlotinib resistance in non-small cell lung cancer
(
- Contribution to journal › Article
- 2018
-
Mark
An Integrative Analysis of Transcriptome and Epigenome Features of ASCL1–Positive Lung Adenocarcinomas
(
- Contribution to journal › Article
-
Mark
Long term safety and visibility of a novel liquid fiducial marker for use in image guided radiotherapy of non-small cell lung cancer
(
- Contribution to journal › Article
- 2016
-
Mark
Liquid fiducial marker performance during radiotherapy of locally advanced non small cell lung cancer
(
- Contribution to journal › Article